Literature DB >> 8584478

A new strategy for enhancing the stability of lyophilized protein: the effect of the reconstitution medium on keratinocyte growth factor.

M Z Zhang1, J Wen, T Arakawa, S J Prestrelski.   

Abstract

PURPOSE: Protein stabilization during lyophilization has previously focused on optimization of the formulation as well as the freezing and dehydration process parameters. However, the effect of the reconstitution medium has been largely neglected. We have investigated its effect on aggregate formation using recombinant keratinocyte growth factor (KGF).
METHODS: The protein was lyophilized under suboptimal conditions to induce aggregation and precipitation upon reconstitution with water. A series of additives were examined by UV spectrophotometry and size exclusion chromatography (SEC-HPLC) for their effects on decreasing the degree of KGF aggregation and precipitation by the increase in recovery of soluble monomer.
RESULTS: Several additives resulted in a significant reduction of aggregation, including sulfated polysaccharides, surfactants, polyphosphates, and amino acids. A similar effect was achieved by adjusting the ionic strength of the reconstitution medium. SEC-HPLC indicated that the amount of soluble monomer was also increased by these additives suggesting that the recovery of the soluble protein correlates with the native, monomeric protein.
CONCLUSIONS: These results suggest that optimization of reconstitution conditions will be a useful methodology for increasing the recovery of soluble, active proteins and that for KGF, the recovery of the soluble protein correlates with the native, monomeric form.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8584478     DOI: 10.1023/a:1016219000963

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Purification and characterization of a newly identified growth factor specific for epithelial cells.

Authors:  J S Rubin; H Osada; P W Finch; W G Taylor; S Rudikoff; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 2.  Stabilization of dry phospholipid bilayers and proteins by sugars.

Authors:  J H Crowe; L M Crowe; J F Carpenter; C Aurell Wistrom
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

3.  Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth.

Authors:  P W Finch; J S Rubin; T Miki; D Ron; S A Aaronson
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

Review 4.  Growth factor-regulated pathways in epithelial cell proliferation.

Authors:  S A Aaronson; J S Rubin; P W Finch; J Wong; C Marchese; J Falco; W G Taylor; M H Kraus
Journal:  Am Rev Respir Dis       Date:  1990-12

5.  Aggregation pathway of recombinant human keratinocyte growth factor and its stabilization.

Authors:  B L Chen; T Arakawa; C F Morris; W C Kenney; C M Wells; C G Pitt
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

6.  Formulation design of acidic fibroblast growth factor.

Authors:  P K Tsai; D B Volkin; J M Dabora; K C Thompson; M W Bruner; J O Gress; B Matuszewska; M Keogan; J V Bondi; C R Middaugh
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

7.  Aggregates formed during storage of beta-galactosidase in solution and in the freeze-dried state.

Authors:  S Yoshioka; Y Aso; K Izutsu; T Terao
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

8.  Freeze denaturation of enzymes and its prevention with additives.

Authors:  T Tamiya; N Okahashi; R Sakuma; T Aoyama; T Akahane; J J Matsumoto
Journal:  Cryobiology       Date:  1985-10       Impact factor: 2.487

9.  The effects of formulation variables on the stability of freeze-dried human growth hormone.

Authors:  M J Pikal; K M Dellerman; M L Roy; R M Riggin
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

10.  Expression of biologically active recombinant keratinocyte growth factor. Structure/function analysis of amino-terminal truncation mutants.

Authors:  D Ron; D P Bottaro; P W Finch; D Morris; J S Rubin; S A Aaronson
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

View more
  7 in total

Review 1.  Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation.

Authors:  Eva Y Chi; Sampathkumar Krishnan; Theodore W Randolph; John F Carpenter
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

2.  Stability of nonaqueous suspension formulations of plasma derived factor IX and recombinant human alpha interferon at elevated temperatures.

Authors:  V M Knepp; A Muchnik; S Oldmark; L Kalashnikova
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

Review 3.  Advanced protein formulations.

Authors:  Wei Wang
Journal:  Protein Sci       Date:  2015-05-01       Impact factor: 6.725

4.  Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stress.

Authors:  Srivalli Telikepalli; Ozan S Kumru; Jae Hyun Kim; Sangeeta B Joshi; Kristin B O'Berry; Angela W Blake-Haskins; Melissa D Perkins; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2014-12-17       Impact factor: 3.534

5.  Strategies to stabilize compact folding and minimize aggregation of antibody-based fragments.

Authors:  Diana Gil; Adam G Schrum
Journal:  Adv Biosci Biotechnol       Date:  2013-04

6.  Characterization of highly concentrated antibody solution - A toolbox for the description of protein long-term solution stability.

Authors:  Marie-Therese Schermeyer; Anna K Wöll; Bas Kokke; Michel Eppink; Jürgen Hubbuch
Journal:  MAbs       Date:  2017-06-15       Impact factor: 5.857

7.  A Bioengineering Approach for the Development of Fibroblast Growth Factor-7-Functionalized Sericin Biomaterial Applicable for the Cultivation of Keratinocytes.

Authors:  Ai Ai Lian; Yuka Yamaji; Kazuki Kajiwara; Keiko Takaki; Hajime Mori; Mervyn Wing On Liew; Eiji Kotani; Rina Maruta
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.